Achieve Life Sciences Inches Closer To FDA Nod For First New Quit-Smoking Drug In 20 Years BY Vandana Singh • August 21, 2025August 22, 2025 Achieve Life Sciences Inc. (NASDAQ:ACHV) is moving closer to a pivotal moment as it seeks FDA approval for cytisinicline, a potential first new smoking cessation therapy in nearly two decades, positio[...] Read more
